UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
151.16
-6.17 (-3.92%)
Jan 28, 2026, 4:00 PM EST
UCB SA Market Cap
UCB SA has a market cap or net worth of $57.43 billion as of January 29, 2026. Its market cap has increased by 58.93% in one year.
Market Cap
57.43B
Enterprise Value
58.94B
Revenue
8.04B
Ranking
n/a
PE Ratio
36.71
Stock Price
$151.16
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 57.43B, an increase of 4,683.15%. That is a compound annual growth rate of 13.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 57.43B | 7.90% |
| Dec 31, 2025 | 53.23B | 40.99% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 458.23M |
| CytoDyn | 317.63M |
| Silence Therapeutics | 241.37M |
| Vaxart | 155.44M |
| BioStem Technologies | 137.76M |
| HST Global | 131.71M |
| Nuo Therapeutics | 76.77M |
| Arch Biopartners | 55.03M |